Gainers
- InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.
- Onion Global Limited (NYSE:OG) gained 113.9% to $0.8556.
- ChemoCentryx, Inc. (NASDAQ:CCXI) gained 110% to $50.68 after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash.
- Minerva Neurosciences, Inc. (NASDAQ:NERV) jumped 80% to $4.8300.
- Greenpro Capital Corp. (NASDAQ:GRNQ) rose 61.1% to $2.82 after climbing around 14% on Tuesday after climbing 28% on Wednesday.
- Missfresh Limited (NASDAQ:MF) shares surged 59.3% to $0.1834 after dropping 7% on Wednesday.
- Quhuo Limited (NASDAQ:QH) gained 51.8% to $0.4966.
- Yellow Corporation (NASDAQ:YELL) rose 44.1% to $6.79 after the company swung to a profit for the second quarter.
- Society Pass Incorporated (NASDAQ:SOPA) gained 42.8% to $2.6700 after reporting 2Q 2022 and 1H 2022 financial results.
- GreenLight Biosciences Holdings (NASDAQ:GRNA) shares gained 39.6% to $4.55 after jumping over 25% on Wednesday. Samsung Biologics and the company recently announced the completion of the first commercial-scale engineering run for the companies’ mRNA production partnership.
- ZW Data Action Technologies Inc. (NASDAQ:CNET) surged 37.5% to $0.79. ZW Data Action Technologies recently collaborated with Forbes Global Alliance to build the Forbes China Group Digital Collection Platform to launch NFT Products and jointly operate the platform data.
- Global Blood Therapeutics, Inc. (NASDAQ:GBT) rose 36.5% to $46.31 following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, citing people familiar with the matter, some large pharmaceutical companies are looking into a potential deal.
- Legacy Housing Corporation (NASDAQ:LEGH) rose 29.9% to $17.55. Legacy Housing will restate its 1st, 2nd, 3rd quarters unaudited interim financial statements for FY21, Reuters reported.
- Forge Global Holdings, Inc. (NYSE:FRGE) jumped 27.8% to $5.82. Forge Global is expected to report Q2 financial results on August 11, 2022.
- Molecular Data Inc. (NASDAQ:MKD) gained 26.3% to $0.7701.
- Waitr Holdings Inc. (NASDAQ:WTRH) surged 26% to $0.4267.
- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) gained 25.5% to $14.00 after the company reported better-than-expected Q2 EPS and sales results. The company also announced the FDA has lifted its partial clinical hold on the BCX9930 program.
- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) shares rose 25.5% to $0.1418 after gaining around 9% on Wednesday.
- Immunic, Inc. (NASDAQ:IMUX) gained 25% to $4.89 following Q2 results.
- NanoViricides, Inc. (NYSE:NNVC) jumped 23.5% to $3.04 after the company announced it has begun drug development to combat Monkeypox virus.
- Exela Technologies, Inc. (NASDAQ:XELA) rose 20.5% to $1.7594 after the company announced an update on its capital deployment strategy. Exela Technologies says the company has purchased $70 million of face value 2026 Senior Secured Notes at a discount with funds raised from equity. This will be the first contribution to the company’s STS (“Serve the Shareholders”) initiative.
- Ashford Inc. (NYSE:AINC) gained 20.1% to $16.78 following Q2 earnings.
- Staffing 360 Solutions, Inc. (NASDAQ:STAF) surged 20% to $3.8462.
- Synthetic Biologics, Inc. (NYSE:SYN) rose 19.4% to $1.77. Synthetic Biologics recently announced a $3 million private placement of convertible preferred stock.
- Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) gained 19.1% to $0.2650.
- TTM Technologies, Inc. (NASDAQ:TTMI) gained 18.5% to $16.01 following upbeat Q2 results.
- Precigen, Inc. (NASDAQ:PGEN) jumped 18.4% to $2.12.
- Exicure, Inc. (NASDAQ:XCUR) shares rose 18.1% to $2.35 after climbing around 27% on Wednesday.
- PagSeguro Digital Ltd. (NYSE:PAGS) climbed 17.8% to $14.41.
- Coinbase Global, Inc. (NASDAQ:COIN) gained 17% to $94.50 after the company announced a partnership with BlackRock.
- Rent-A-Center, Inc. (NASDAQ:RCII) climbed 16% to $29.49 following upbeat quarterly earnings.
- MercadoLibre, Inc. (NASDAQ:MELI) rose 15.9% to $1,032.06 following better-than-expected quarterly results.
- Ampio Pharmaceuticals, Inc. (NYSE:AMPE) rose 15.7% to $0.1196 after dipping around 34% on Wednesday.
- Applied DNA Sciences, Inc. (NASDAQ:APDN) gained 15.8% to $4.75 as the company reported pricing of $12 million upsized offering.
- Altice USA, Inc. (NYSE:ATUS) surged 15.5% to $11.17 following strong quarterly sales.
- Pintec Technology Holdings Limited (NASDAQ:PT) jumped 15.5% to $1.19.
- Sprouts Farmers Market, Inc. (NASDAQ:SFM) surged 15% to $31.24 following better-than-expected quarterly results.
- Amesite Inc. (NASDAQ:AMST) gained 14.6% to $0.4934.
- Insmed Incorporated (NASDAQ:INSM) jumped 13.7% to $24.76 following narrower-than-expected Q2 loss.
- Arcosa, Inc. (NYSE:ACA) jumped 13.4% to $58.18 after reporting upbeat Q2 results.
- Digital Brands Group, Inc. (NASDAQ:DBGI) rose 13.3% to $0.1360. Digital Brands Group, last month, received a determination letter from the Nasdaq stating that the Company has not regained compliance.
- ATI Inc. (NYSE:ATI) gained 11.5% to $28.26 after reporting strong quarterly results.
- Gol Linhas Aéreas Inteligentes S.A. (NYSE:GOL) gained 11.2% to $3.78 after the company reported preliminary traffic figures for July 2022.
- Advanced Drainage Systems, Inc. (NYSE:WMS) jumped 10.8% to $133.48 after the company reported better-than-expected Q1 EPS and sales results and issued FY23 sales guidance above estimates.
- Hecla Mining Company (NYSE:HL) gained 9.3% to $4.82 following upbeat Q2 results.
- Benitec Biopharma Inc. (NASDAQ:BNTC) rose 8.7% to $0.86.
- Installed Building Products, Inc. (NYSE:IBP) gained 7.7% to $105.32 following Q2 results.
- Huntington Ingalls Industries, Inc. (NYSE:HII) jumped 7.1% to $234.24 as the company reported a second-quarter sales and service revenue increase of 19.3% year-over-year to $2.662 billion, beating the consensus of $2.62 billion.
- American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) shares rose 6.3% to $0.1861.
- Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) rose 5% to $0.9227. The European Medicines Agency issued a positive opinion on Syros Pharmaceuticals’ application for orphan drug designation for tamibarotene for myelodysplastic syndrome (MDS).
- Novo Nordisk A/S (NYSE:NVO) rose 3.7% to $103.60. Novo Nordisk reported Q2 sales of DKK41.27 billion, +25% Y/Y (+15% on a constant currency basis).
Don’t forget to check out our premarket coverage here .
Losers
- AMTD Digital Inc. (NYSE:HKD) dipped 43.6% to $620.00 on possible profit taking after the stock surged over the last few trading days.
- Timber Pharmaceuticals, Inc. (NYSE:TMBR) dropped 39.9% to $0.1038 after the company announced a public stock offering of approximately 66.67 million shares at $0.12 per share.
- AMTD IDEA Group (NASDAQ:AMTD) fell 36.2% to $3.9709 after dropping over 10% on Wednesday.
- Helius Medical Technologies, Inc. (NASDAQ:HSDT) fell 35.5% to $1.02 after surging 145% on Wednesday.
- SiTime Corporation (NASDAQ:SITM) dipped 33.8% to $138.70. SiTime posted upbeat quarterly results, but lowered its forecast for the year.
- Vapotherm, Inc. (NYSE:VAPO) fell 29.5% to $1.8047 after the company reported Q2 EPS results down year over year and worse-than-expected Q2 sales results. Additionally, multiple firms downgraded the stock following the company’s Q2 earnings results.
- Paymentus Holdings, Inc. (NYSE:PAY) dropped 29.4% to $12.79 following weak quarterly earnings.
- Gannett Co., Inc. (NYSE:GCI) fell 28% to $2.31 after the company reported worse-than-expected Q2 sales results.
- Aris Water Solutions, Inc. (NYSE:ARIS) dipped 27% to $16.10 after the company reported Q2 results and announced acquisition of the assets of Delaware Energy Services, LLC.
- Leafly Holdings, Inc. (NASDAQ:LFLY) fell 26.5% to $3.75.
- U.S. Physical Therapy, Inc. (NASDAQ:USPH) dipped 25.5% to $94.55 following weak quarterly results.
- Kaspien Holdings Inc. (NASDAQ:KSPN) dropped 24.4% to $4.69.
- Forafric Global PLC (NASDAQ:AFRI) fell 24.3% to $7.56.
- Kaspien Holdings Inc. (NASDAQ:KSPN) shares fell 23.3% to $4.76 after jumping 140% on Wednesday.
- Atento S.A. (NYSE:ATTO) dipped 22.2% to $6.69 following Q2 results.
- Connexa Sports Technologies Inc. (NASDAQ:CNXA) dropped 21.9% to $1.14.
- InfuSystem Holdings, Inc. (NYSE:INFU) fell 21% to $7.84 following Q2 results.
- Liquidity Services, Inc. (NASDAQ:LQDT) dropped 20.7% to $17.77 following Q3 results.
- MediaCo Holding Inc. (NASDAQ:MDIA) fell 20.4% to $4.5001 after jumping 49% on Wednesday.
- United Fire Group, Inc. (NASDAQ:UFCS) dipped 20.3% to $25.74 following weak quarterly sales.
- 8×8, Inc. (NYSE:EGHT) dropped 20% to $4.4898. MKM Partners initiated coverage on 8×8 with a Neutral rating and announced a price target of $5.5.
- DXC Technology Company (NYSE:DXC) declined 18.8% to $25.61 following downbeat quarterly results.
- Ecovyst Inc. (NYSE:ECVT) fell 18.4% to $8.74 as the company reported upsize and pricing of secondary offering of 13,000,000 shares of common stock by selling stockholders and repurchase of common stock.
- Ball Corporation (NYSE:BALL) dropped 18% to $59.77.
- Heart Test Laboratories, Inc. (NASDAQ:HSCS) fell 17.4% to $2.71 after gaining around 90% on Wednesday.
- Ocwen Financial Corporation (NYSE:OCN) dropped 17.2% to $29.14 following earnings miss.
- Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) fell 16.8% to $16.45 after surging 360% on Wednesday.
- YETI Holdings, Inc. (NYSE:YETI) dipped 16.8% to $45.21 after the company reported worse-than-expected Q2 EPS and sales results and cut FY22 adjusted EPS guidance.
- Enveric Biosciences, Inc. (NASDAQ:ENVB) shares fell 16.6% to $10.92 after jumping 106% on Wednesday. Enveric Biosciences recently announced an $8 million registered direct offering and private placement.
- Fortinet, Inc. (NASDAQ:FTNT) fell 16.6% to $52.44 after the company issued in-line guidance and slightly lowered its FY22 service revenue outlook.
- MMTec, Inc. (NASDAQ:MTC) fell 16% to $4.3291 after dropping over 34% on Wednesday.
- Tandem Diabetes Care, Inc. (NASDAQ:TNDM) dipped 15.1% to $58.58. Tandem Diabetes Care posted a Q2 loss of $0.24 per share.
- Medifast, Inc. (NYSE:MED) fell 15% to $145.95 after the company lowered its FY22 forecast.
- Itron, Inc. (NASDAQ:ITRI) dropped 14.6% to $50.06 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 adjusted EPS and sales guidance below estimates.
- Revolve Group, Inc. (NASDAQ:RVLV) shares fell 14.3% to $26.52 following downbeat Q2 results.
- GeoVax Labs, Inc. (NASDAQ:GOVX) fell 13.9% to $2.3591. Geovax Labs posted a Q2 loss of $0.21 per share.
- Perficient, Inc. (NASDAQ:PRFT) dropped 13.2% to $95.00 after the company reported worse-than-expected Q2 sales results and issued Q3 and FY22 sales guidance below estimates.
- Crocs, Inc. (NASDAQ:CROX) fell 13% to $67.30.
- American Rebel Holdings, Inc. (NASDAQ:AREB) fell 11.8% to $0.8830 after climbing over 58% on Wednesday.
- Crown Holdings, Inc. (NYSE:CCK) fell 11.3% to $88.06.
- Lucid Group, Inc. (NASDAQ:LCID) fell 10.3% to $18.40 following weak quarterly sales.
- Poseida Therapeutics, Inc. (NASDAQ:PSTX) fell 10.1% to $4.0550 after the company reported pricing of public offering of common stock.
- Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) fell 8% to $4.5999 after dropping 29% on Wednesday.
- The Clorox Company (NYSE:CLX) fell 5.9% to $136.11 following downbeat quarterly sales.
